Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Epirubicin Hydrochloride for Injection

Approval Number

国药准字H20183145

Company浙江海正药业股份有限公司

Registration Date

December 20, 2022

Previous Approval Numbers

国药准字H20183145

Drug Information

Generic Name

注射用盐酸表柔比星

Dosage Form

注射剂

Strength

10mg

Drug Type

化学药品

Registration Date

December 20, 2022

Company Information

Applicant Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省台州市椒江区外沙路46号

Manufacturing Company

Company Name

浙江海正药业股份有限公司;瀚晖制药有限公司

Company Address

浙江省杭州市富阳区胥口镇海正路10号；浙江省杭州市富阳区胥口镇海正路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用盐酸表柔比星 - NMPA 批准文号 | MedPath